This inventor holds 19 USPTO granted patents and 7 published patent applications, plus 5 CIPO patents and 4 EPO patents, primarily in Cancer Therapeutics. Top assignees: Millennium Pharmaceuticals Limited, Eisai R&d Management Co., Ltd., Dana-Farber-Cancer Institute Inc.. Active years: 2013-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Malden, MA (US) (2013 - 2019)
- Winchester, MA (US) (2014 - 2020)
- Shanghai, CN (2020)
- Cambridge, MA (US) (2023 - 2024)
Company Filing History:
8 out of 855 
7 out of 530 
2 out of 1,272 
Years Active: 2013-2025
Areas of Expertise:
Title: Innovator Profile: Yongbo Hu - Pioneering Inventions in Cancer Treatment
Introduction:
Yongbo Hu is a distinguished inventor based in Winchester, MA, renowned for his groundbreaking work in developing innovative compounds for cancer treatment. With a patent portfolio boasting 9 patents, his contributions have significantly advanced the field of oncology.
Latest Patents:
Hu's latest patents include the development of STING modulator compounds for the prophylaxis and treatment of cancer and other STING-related diseases. These compounds, represented by specific formulas, offer promising avenues for novel therapeutic interventions. Additionally, his work on heteroaryls as inhibitors of VPS34 showcases his commitment to tackling proliferative, inflammatory, and cardiovascular disorders.
Career Highlights:
Having made substantial contributions to the pharmaceutical industry, Hu has lent his expertise to esteemed companies such as Millennium Pharmaceuticals Limited and Takeda Pharmaceutical Company Limited. By leveraging his inventive prowess, he has played a vital role in driving innovation and progress in the field of drug discovery and development.
Collaborations:
Throughout his career, Hu has collaborated closely with accomplished professionals in the industry, including Tianlin Xu and Stepan Vyskocil. These collaborations have not only enriched his own research endeavors but have also fostered a culture of knowledge exchange and synergy within the scientific community.
Conclusion:
Yongbo Hu's dedication to pioneering research in cancer therapeutics has positioned him as a leading figure in the realm of biomedical innovation. His relentless pursuit of novel solutions underscores his commitment to improving patient outcomes and addressing unmet medical needs. As he continues to push the boundaries of invention, the impact of his work is sure to reverberate across the landscape of modern medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile